The first psychobiotic in Brazil
Published on 14/10/2020
Apsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the brain-gut axis on the Brazilian market, with approved health claims by the Brazilian Health Authorities, ANVISA.
Probid and Probians, produced by Lallemand Health Solutions, are available to the Brazilian market since September 2020. “We are proud to be the first in Brazil to launch a specific probiotic formulation, based on two strains known for their proven effects on stress level and mood balance”, affirmed Kleber Vargas, technical and business development vice-president at Apsen. “Apsen invested in research to provide this evolution to the Brazilian market, with an innovative product with a full array of health benefits.” Adds Kleber Vargas.
Probid and Probians contain the documented probiotic combination of Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175 which has been recognized by the Brazilian Health Authorities for its safety and benefits in stressed healthy individuals. The claims approved by the regulatory agency for health products in Brazil, ANVISA, are:
- Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 may contribute to the reduction of feelings of anxiety in healthy individuals.
- Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 contribute to the reduction of gastrointestinal complications such as abdominal pain and nausea/vomit brought on by light to moderate stress in healthy individuals.
This specific probiotic formula is demonstrated to promote positive mood in stressful events and can help moderate physiological (Diop 2008) and psychological (Messaoudi 2010, 2011) responses to occasional stress. It is the most documented psychobiotic with five clinical studies and several pre-clinical studies allowing to highlight eight mechanisms of action on the brain-gut axis. The modes of action for this formula have been documented by nine mechanistic studies and five human studies on the brain-gut axis.